Andersen Consulting broadens its capabilities in Cambodia, Vietnam, and Laos as VDB Loi brings consulting capabilities to its existing tax and legal offering. Led by Managing Director Jean Loi, who also serves as managing director for Andersen in Cambodia and Vietnam, VDB Loi was founded in 2012 as a tax and legal firm and has been a collaborating firm of Andersen Global since 2021. With the addition of its full suite of consulting services, VDB Loi is now a member of Andersen Consulting offe...

When the global telecom industry gathers in Paris for Network X 2025 (October 14 - 16), attendees can expect more than keynote speeches and panel debates. This year’s edition unites the sector’s most influential players under one roof with an interactive expo floor and new event features. From AI-powered broadband networks and 5G monetisation to sustainable infrastructure and satellite connectivity, leading technology sponsors, live demonstrations and dynamic stage presentations will showcase t...

OPEX® Corporation, a global leader in Next Generation Automation providing innovative solutions for document and mail automation, has entered into a partnership agreement with DATAWIN GmbH, a leading manufacturer of premium document scanners, enabling OPEX to offer DATAWIN’s InoTec document scanners at the global level. For DATAWIN, based in Ergolding near Landshut, Germany, this alliance opens new international markets, as it represents the company’s first global distribution partnership. DA...

SK Capital Partners, LP (“SK Capital”), a New York-based private investment firm focused on the specialty materials, ingredients, and life sciences sectors, has completed the previously announced acquisition of LISI Group’s (Euronext: FII) Medical division (the “Transaction”). The business has relocated its headquarters to Big Lake, Minnesota and has been renamed Precera Medical (“Precera Medical” or the “Company”), marking its emergence as a leading contract development and manufacturing organ...

Onego Bio, a food ingredient company producing egg protein through precision fermentation, announced today that the U.S. Food and Drug Administration (FDA) has issued a “no questions” letter regarding the company’s conclusion that its flagship product, marketed as Bioalbumen®, is Generally Recognized As Safe (GRAS) under its conditions of use in a wide range of food and beverage applications. The FDA’s decision, communicated in response to GRAS Notice No. GRN 1249, confirms that Bioalbumen®—a...